Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2003
10/02/2003US20030186319 Comprises nucleotide sequences coding membrane protein for use as antiinflammatory/antitumor/anticarcinogenic/ antiproliferative agents
10/02/2003US20030186318 Comprises nucleotide sequences coding membrane protein for use as antiinflammatory/antitumor/anticarcinogenic/ antiproliferative agents
10/02/2003US20030186317 Identifying modulators of calcium-binding protein (CIB)/mixed lineage kinase 2 (MLK2) complexes for treatment and prevention of nervous system disorders
10/02/2003US20030186308 Prostacyclin-stimulating factor-2
10/02/2003US20030186306 Nucleotide sequences coding interleukins for treating tumors, bone, nervous system, neovascularization and autoimmune disorders
10/02/2003US20030186305 Novel proteins
10/02/2003US20030186294 Method of diagnosing and treating lesion of crystalline lens using human crygs gene and coding product thereof
10/02/2003US20030186290 Gene involved in CADASIL, method of diagnosis and therapeutic application
10/02/2003US20030186286 Suppressor of cytokine signaling (SOCS)-3 promoter and methods for its use in genetic therapy in humans
10/02/2003US20030186283 Azodicarbonamide ejects zinc bound to protein; solid phase synthesis; nuclear magnetic resonance
10/02/2003US20030186273 Using transport protein to treat cardiovascular and neovascularization disorders
10/02/2003US20030186271 Pharmaceutical compositions in particulate form
10/02/2003US20030186269 Ssa-56 kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
10/02/2003US20030186267 Novel human leucine-rich repeat domain containing protein, HLLRCR-1
10/02/2003US20030186265 Novel human G-protein coupled receptor, HGPRBMY7, expressed highly in spinal cord
10/02/2003US20030186253 Fibroblast growth factor-13
10/02/2003US20030186244 Using stored nucleotide sequence information to screen genome databases to detect restriction fragment length polymorphisms which are associated with genetic disorders
10/02/2003US20030186232 Human and non-human primate homologues of Nkd protein, nucleic acid sequences encoding, and uses thereof
10/02/2003US20030186225 Comprises DNA sequences coding viral protein for use in developing vaccine which prevents porcine reproductive and respiratory syndrome viral infections
10/02/2003US20030186224 CD4+ T-lymphocyte-specific hepatitis C virus-epitopes
10/02/2003US20030186219 Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and use of these DNA clones and polypeptides in diagnostic kits
10/02/2003US20030185905 Plant extracts for the treatment of increased bone resorption
10/02/2003US20030185898 Cartilage-Derived morphogenetic proteins
10/02/2003US20030185897 Composition comprising zoanthus sp. extract with anti-fouling activity and a method thereof
10/02/2003US20030185890 Compositions and methods for polynucleotide delivery
10/02/2003US20030185860 Administering directly to a blood vessel
10/02/2003US20030185857 Recombinant urine derived protein capable of binding to a purified HBV derived polypeptide
10/02/2003US20030185855 Which has lost its transducing properties as a result of a DNA sequence change in the gene coding for Vmw65 protein; expressable heterologous gene inserted; under the control of the immediate early 1 gene enhancer of cytomegalovirus
10/02/2003US20030185853 Produced by inoculating koji mold on a pulse crop to effect koji preparation and adding water to hydrolyze proteins and/ or saccharides contained in said product
10/02/2003US20030185849 React with convalescent phase antiserum from an E. canis-infected dog; useful in the development of vaccines and serodiagnostics
10/02/2003US20030185844 Isolated nucleic acid molecules encoding isolated peptides which correspond to contiguous amino acids of an SSX molecule or NY-ESO-1 and uses thereof
10/02/2003US20030185843 Heat shock protein-based vaccines and immunotherapies
10/02/2003US20030185842 Heat shock protein-based vaccines and immunotherapies
10/02/2003US20030185839 Local administration of trefoil peptides.
10/02/2003US20030185838 Administration of intestinal trefoil peptides.
10/02/2003US20030185834 Administering an anti-angiogenesis factor to localize in the choroidal neovasculature; administering photosensitizer; photodynamic therapy by irradiating with laser light
10/02/2003US20030185832 Administering a targeting agent operatively attached to a therapeutic agent; the targeting agent recognizes and binds to a tumor-associated endothelial cell marker.
10/02/2003US20030185830 Compositions and methods for the therapy and diagnosis of prostate cancer
10/02/2003US20030185829 Jagged 2 inhibitors for inducing apoptosis
10/02/2003US20030185828 For treating osteoarthritis
10/02/2003US20030185827 Stimulating remyelination of central nervous system axons by administering a monoclonal antibody characterized by their ability to bind structures and cells within the central nervous system, including oligodendrocytes.
10/02/2003US20030185826 Administering as a TNF antagonist for reducing neuronal tissue inflammation a fusion protein identified as etanercept, infliximab, CDP571, CDP 870, D2E7, soluble TNF receptor Type I, or pegylated soluble TNF receptor Type I
10/02/2003US20030185825 Novel immunotoxins and methods of inducing immune tolerance
10/02/2003US20030185824 Administering an inhibitor of the CD2/LFA-3 interaction, in combination with an auxiliary agent, such as UV-B
10/02/2003US20030185823 Arming of activated T cells with BiAbs increases the effective precursor frequency of CTL in the cancer patient.
10/02/2003US20030185822 HLA-A2.1 binding peptides and their uses
10/02/2003US20030185821 Antibodies to interleukin-4 receptors and uses thereof
10/02/2003US20030185820 Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same, and methods of use thereof
10/02/2003US20030185819 Treatment of specific and non-specific inflammation, including asthma; useful in diagnosing and localizing sites of inflammation.
10/02/2003US20030185818 Humanized antibody against cd18
10/02/2003US20030185815 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
10/02/2003US20030185814 Ceramidase
10/02/2003US20030185812 Injecting the plasma, especially containing calcium chloride or thrombin, into an epidural space.
10/02/2003US20030185810 Tumor radiosensitization using gene therapy
10/02/2003US20030185809 First population of mammalian cells transfected or transduced with a gene that is sought to be expressed, and a second population of mammalian cells that have not been transfected or transduced with the gene
10/02/2003US20030185806 Intact cells that express major histocompatibility antigens with a number of common allotypes from a given mammalian species.
10/02/2003US20030185800 Human interferon-epsilon: a type I interferon
10/02/2003US20030185799 Treatment of hepatitis C with thymosin and peptide combination therapy
10/02/2003US20030185798 Biocompatible polymers including peptide spacer
10/02/2003US20030185797 Synferon
10/02/2003US20030185795 G-CSF molecules to which three or more polymer molecules are attached (especially polyethylene glycol) to provide resistance against proteolysis and to allow uptake into the blood stream from the intestine.
10/02/2003US20030185794 Such as a pleiotrophin or midkine molecule in a pharmaceutically acceptable carrier.
10/02/2003US20030185791 TNF-derived peptides for use in treating oedema
10/02/2003US20030185790 Methods of ex-vivo expansion of hematopoeitic cells using multivariant IL-3 hematopoiesis chimera proteins
10/02/2003US20030185765 Composition for pulmonary administration comprising a drug and a hydrophobic amino acid
10/02/2003US20030185761 Buccal, polar and non-polar spray or capsule containing drugs for treating pain
10/02/2003US20030185756 Carbocyanine dye for visualization, photosensitizer for photodynamic treatment, and tumor receptor-avid peptide for site-specific delivery of the probe and phototoxic agent to diseased tissues
10/02/2003US20030185755 Novel ectoparasite saliva proteins and apparatus to collect such proteins
10/02/2003CA2481556A1 Modified plasminogen activator inhibitor type-1 and methods based thereon
10/02/2003CA2480388A1 Methods and compounds for prevention and treatment of elevated intraocular pressure and related conditions
10/02/2003CA2480302A1 Compositions and methods for treating and preventing necrosis
10/02/2003CA2480100A1 Alertness bar
10/02/2003CA2480099A1 Erbb3 based methods and compositions for treating neoplasms
10/02/2003CA2480050A1 Tenascin-w compositions and uses thereof
10/02/2003CA2480034A1 Antibody fusion proteins: effective adjuvants of protein vaccination
10/02/2003CA2480005A1 Heat-reversible composition treating hyposalia and asialia
10/02/2003CA2479893A1 Maleic acid salt of (2s)-n-{5-¬amino(imino)methyl|-2-thienyl}methyl-1-{(2r)-2-¬(carboxymethyl)amino|3,3-diphenylpropanoyl}-2-pyrrolidine carboxamide and a process for preparing the same
10/02/2003CA2479888A1 New crystalline forms of (2s)-n-5-¬amino(imino)methyl|-2-thienylmethyl-1-(2r)-2-¬(carboxymethyl)amino|-3,3-diphenylpropanoyl-2-pyrrolidinecarboxamide nh2o
10/02/2003CA2479732A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/02/2003CA2479731A1 Novel compositions and methods in cancer associated with altered expression of tbx21
10/02/2003CA2479730A1 Novel compositions and methods in cancer
10/02/2003CA2479727A1 Novel compositions and methods in cancer associated with altered expression of kcnj9
10/02/2003CA2479721A1 Novel compositions and methods in cancer associated with altered expression of prlr
10/02/2003CA2479719A1 Novel compositions and methods in cancer associated with altered expression of mcm3ap
10/02/2003CA2479530A1 Hiv therapeutic
10/02/2003CA2479306A1 Egfr ligands and methods of use
10/02/2003CA2478974A1 Inhalable sustained therapeutic formulations
10/02/2003CA2478855A1 Use of il-18 inhibitors for the treatment and/or prevention of peripheral vascular diseases
10/02/2003CA2478839A1 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
10/02/2003CA2478801A1 Method for administration of growth hormone via pulmonary delivery
10/02/2003CA2478629A1 Method and apparatus for producing dry particles
10/02/2003CA2478327A1 Hgh (human growth hormone) formulations for pulmonary administration
10/02/2003CA2478063A1 Lymphatic and blood endothelial cell genes
10/01/2003EP1348768A2 Method of treatment, diagnosis or detection of diabetes
10/01/2003EP1348715A2 CD19xCD3 specific polypeptides and uses thereof
10/01/2003EP1348714A1 Polypeptide useful as anti-allergic/antiasthmatic, methods for the preparation thereof and pharmaceutical compositions containing such polypeptide and their use
10/01/2003EP1348460A2 Creating an aerosolized formulation of insulin
10/01/2003EP1348440A1 Use of angiotensin 1-7 for enhancing cardiac function
10/01/2003EP1348428A1 Powdery preparations and proecss for producing the same
10/01/2003EP1348427A1 Ophthalmic compositions containing galactomannan polymers and borate
1 ... 1760 1761 1762 1763 1764 1765 1766 1767 1768 1769 1770 1771 1772 1773 1774 1775 1776 1777 1778 1779 1780 ... 3163